Edwards Lifesciences Ownership

Edwards Lifesciences holds a total of 589.8 Million outstanding shares. The majority of Edwards Lifesciences Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Edwards Lifesciences Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Edwards Lifesciences. Please pay attention to any change in the institutional holdings of Edwards Lifesciences Corp as this could imply that something significant has changed or is about to change at the company. On November 11, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Edwards Lifesciences Corp's common stock. Some institutional investors establish a significant position in stocks such as Edwards Lifesciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Edwards Lifesciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to climb to about 233.1 M in 2024, whereas Dividend Paid And Capex Coverage Ratio is likely to drop 3.15 in 2024. Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 550.8 M in 2024. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.